RT Journal Article
SR Electronic
A1 Zarifyan, Alla
T1 ARTS-HF Study
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28
SP 16
OP 16
DO 10.1177/1559897715611883
UL http://mdc.sagepub.com/content/15/28/16.abstract
AB ARTS-HF study demonstrated that finerenone had a comparable efficacy with eplerenone in reducing N-terminal pro-brain natriuretic peptide and a greater efficacy in reducing the incidence of the composite of all-cause death, cardiovascular hospitalization, or emergency presentation for worsening chronic heart failure in patients with heart failure with reduced ejection fraction and type 2 diabetes or chronic kidney disease. However, caution is required in interpreting the results because it was an exploratory, underpowered study.